What is Amgen's common stock?

Amgen (AMGN) reported common stock of 2.8B in Q1 2026.

How has Amgen's common stock changed year-over-year?

Amgen's common stock decreased by 0.0% year-over-year, from 2.8B to 2.8B.

What is the long-term trend for Amgen's common stock?

Over 5 years (2020 to 2025), Amgen's common stock has grown at a -38.7% compound annual growth rate (CAGR), from 31.8B to 2.8B.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Amgen AMGN Common Stock

Common Stock at other companies

Eli LillyLLY

$590M-0.4%

Nektar TherapeuticsNKTR

390M+30.0%

Oruka Therapeutics, Inc.ORKA

545M0.0%

Rigel PharmaceuticalsRIGL

$18K0.0%

Jazz PharmaceuticalsJAZZ

$0-100%

AnaptysBio, Inc.ANAB

$29K-3.3%

Other financials

Income statement

See full

Revenue$8.6B+5.8%

Gross profit$5.9B+13.4%

Operating income$2.7B+126%

Net income$1.8B+5.1%

EPS (diluted)$3.34+4.4%

Balance sheet

See full

Cash & equivalents$559.0M+10.0%

Total debt$57.3B-0.1%

Total equity$9.2B+48.1%

Total assets$92.5B+3.5%

Cash flow

See full

Operating cash flow$2.2B+57.4%

CapEx$712.0M+73.2%

Free cash flow$1.5B+50.7%

Valuation

See full

Market cap$200.5B+20.9%

Enterprise value$257.27B+16.1%

P/E25.7×+0.6×

P/S5.4×+0.6×

Profitability

See full

Gross margin68.3%+5.3pp

Operating margin28.4%+6.6pp

Net margin21%+3.6pp

FCF margin23.1%-8.9pp

Returns & leverage

See full

Return on equity101.3%-4.4pp

Debt / equity6.2×-3.0×

Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amgen's common stock?: Amgen (AMGN) reported common stock of 2.8B in Q1 2026.
How has Amgen's common stock changed year-over-year?: Amgen's common stock decreased by 0.0% year-over-year, from 2.8B to 2.8B.
What is the long-term trend for Amgen's common stock?: Over 5 years (2020 to 2025), Amgen's common stock has grown at a -38.7% compound annual growth rate (CAGR), from 31.8B to 2.8B.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).